Comment on ‘Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'

Willemse

• Publication year

  2013

• Venue

  British Journal of Cancer

• Publication date

  2013-09-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bjc.2013.566PMID 24045657PMCID 3817322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early development of the metabolic syndrome after chemotherapy for testicular cancer.

  2013cited by this paper
• Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

  2013influential reference
• Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?

  2010cited by this paper
• Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse

  2008cited by this paper
• Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.

  2008cited by this paper
• EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

  2008cited by this paper
• Framingham risk score and prediction of coronary heart disease death in young men.

  2007cited by this paper
• Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.

  2007cited by this paper
• The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

  2006cited by this paper
• Components of the metabolic syndrome in long-term survivors of testicular cancer.

  2006cited by this paper
• Fertility, Gonadal and Sexual Function in Survivors of Testicular Cancer

  2006cited by this paper
• Fertility, gonadal and sexual function in survivors of testicular cancer

  2005cited by this paper
• European guidelines on cardiovascular disease prevention in clinical practice

  2004cited by this paper
• Cardiovascular disease as a long-term complication of treatment for testicular cancer.

  2003cited by this paper

• Long-term Testis Cancer Survivors in Canada—Mortality Risks in a Large Population-based Cohort

  2020cites this paper
• Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act.

  2020cites this paper
• Low Testosterone in Male Cancer Patients and Survivors.

  2020cites this paper
• Subclinical Arteriosclerosis is Associated with Common Vascular Risk Factors in Long-Term Survivors of Testicular Cancer

  2020cites this paper
• [Side effects of chemotherapy for testicular cancers and post-cancer follow-up].

  2019cites this paper
• Risk factors for cardiovascular disease in 5‐year survivors of adolescent and young adult cancer: A Danish population‐based cohort study

  2019cites this paper
• Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study

  2018cites this paper
• Cancer Survivorship in Adults.

  2018cites this paper
• Testicular cancer guideline adherence and patterns of care in Germany: A nationwide survey

  2018cites this paper
• Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers

  2017cites this paper
• Recent developments in the management of germ cell tumors

  2017cites this paper
• Wie tief sitzt der Schmerz?

  2017cites this paper
• Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle.

  2016cites this paper
• Long-term health effects among testicular cancer survivors

  2016cites this paper
• Taste and smell function in testicular cancer survivors treated with cisplatin-based chemotherapy in relation to dietary intake, food preference, and body composition.

  2016cites this paper
• ATRIAL FIBRILLATION DOUBLED IN-HOSPITAL MORTALITY IN 1379 ACUTE CARDIOGENIC PULMONARY EDEMA PATIENTS

  2016cites this paper
• RISK FACTORS AND INDICATORS OF CARDIOVASCULAR ILLNESSES IN LATE ADOLESCENT PERIOD

  2016cites this paper
• Testicular germ cell tumours.

  2016cites this paper
• [Germ cell tumor in adolescents and young adults].

  2016cites this paper
• Testicular cancer – response adapted treatment, prognostic markers and survivorship issues

  2015cites this paper
• Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.

  2015cites this paper
• Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship

  2015cites this paper
• Consequences of the Disease and Its Treatment Concerning Sexuality and Fertility

  2015cites this paper
• Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies.

  2015cites this paper
• Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study

  2014cites this paper
• Skeletal and metabolic complications of testicular germ cell tumours.

  2014cites this paper
• Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'

  2013influential citation